Devgen and Leads Agri Sign Agreement for Distribution of Devgen's Hybrid Rice Seed Products in the Philippines
News May 15, 2009
Devgen and Leads Agri have announced the signing of an agreement for the distribution by Leads Agri of Devgen's hybrid rice products for the Philippine territory.
Both companies will combine their respective expertise. Leads Agri is said to be a market leader in the distribution of high quality agrochemicals in the Philippines with country wide presence. Devgen is an important player in the field of hybrid rice seed breeding, production and marketing in India benefiting from a global technology platform.
Devgen furthermore established a presence in the Philippines with breeding stations, working on a pipeline for tropical hybrid rice, and production of hybrid rice seed in Mindanao for the Philippine market.
Under this synergistic distribution collaboration, Devgen and Leads Agri will jointly promote Devgen's hybrid rice product with Leads Agri's chemical solutions to provide a complete solution for the Philippine rice farmers. The hybrid seeds will be sold under Devgen's "Frontline" brand name.
"It is a pleasure to work with Leads Agri, one of the leading distributors in the Philippines for agrochemical products", says Thierry Bogaert, CEO of Devgen, "Leads Agri shares our philosophy of building a strong relationship with the farmer."
Fernando Malvedo, CEO of Leads Agri says: "We are deeply honored by the trust & confidence that Devgen, a global force in Hybrid seeds has given to Leads Agri. As the leading Filipino crop protection company , it is our earnest desire to continue serving the Filipino farmers not only with high quality crop protection products but also provide the latest in biotechnology i.e. hybrid rice which will help them achieve a high level of productivity that will result to their economic upliftment. With the hybrid seeds in its product portfolio, Leads Agri is now in a much better position to further strengthen its position as the 3rd largest crop protection company in the Philippines, only behind the two giant multinational companies."
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.